Myth #3: GLP-1 agonists are a quick fix for weight loss Many people mistakenly believe that GLP-1 agonists offer a quick and effortless solution to weight loss, expecting rapid results with minimal effort
Sowndhararajan K, Deepa P, Kim M, Park SJ, Kim S
While its efficacy and safety profile are comparable to oral Wegovy , it falls significantly short of Eli Lillys subcutaneous tirzepatide the gold standard of GLP-1 analogs to date (technically a dual agonist mimicking both GLP-1 and GIP)
It may indicate heart strain or other cardiovascular issues triggered by Albuterol
Many patients on GLP-1 therapy are eating less overall, which means dietary calcium intake may drop below the threshold needed for bone maintenance
The restrictions are, in women, due to the potential for birth defects in children born of women of childbearing age